Development of genetically coherent models of Sandhoff disease generated by disruption of the Hexb gene in embryonic stem cells in mice [10], [11] provides a platform for pathological and therapeutic investigation of GM2 gangliosidoses. This evidence concerns the gene HEXB and Sandhoff disease.